B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Amg 900

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Amg 900, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

lenvatinib
11 shared targets
cep
12 shared targets
fasudil
8 shared targets
pf
16 shared targets
azd
14 shared targets
k
17 shared targets
orantinib
9 shared targets
bafetinib
9 shared targets
regorafenib
9 shared targets
gsk
10 shared targets
Loading evidence profile...

This evidence profile for Amg 900 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.